SCHEMBL16397642

SCHEMBL16397642

O=Cc1cc(Br)cc(OC2CCC2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.38
PARP10 Q53GL7 1/20 0.38
ALDH1A1 P00352 3/20 0.37
SLC6A2 P23975 2/20 0.36
SLC6A4 P31645 2/20 0.36
SLC6A3 Q01959 1/20 0.34
HPGD P15428 1/20 0.34
MAOA P21397 2/20 0.33
MAOB P27338 2/20 0.33
THRA P10827 2/20 0.33
THRB P10828 2/20 0.33
GRIN2D O15399 1/20 0.33
GRIN3B O60391 1/20 0.33
GRIN1 Q05586 1/20 0.33
GRIN2A Q12879 1/20 0.33
GRIN2B Q13224 1/20 0.33
GRIN2C Q14957 1/20 0.33
GRIN3A Q8TCU5 1/20 0.33
HDAC4 P56524 1/20 0.32
MEF2D Q14814 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18003236 0.98 POLB (0.40) POLBPARP10ALDH1A1SLC6A2SLC6A4
SCHEMBL16247030 0.85 HPGD (0.42) POLBPARP10ALDH1A1HPGDMAOB
SCHEMBL16399167 0.85 SLC6A2 (0.41) POLBPARP10ALDH1A1SLC6A2SLC6A4
SCHEMBL18003168 0.84 SLC6A2 (0.32) ALDH1A1SLC6A2SLC6A4SLC6A3
SCHEMBL6122852 0.81 BRD4 (0.39) FFAR4KMT2A
SCHEMBL18003876 0.81 SLC6A2 (0.41) POLBPARP10ALDH1A1SLC6A2SLC6A4
SCHEMBL16406695 0.79 FFAR1 (0.37) POLBPARP10ALDH1A1HPGDMAOB
SCHEMBL5610574 0.79 CYP1A1 (0.42) POLBALDH1A1KMT2AABL1PPARG
SCHEMBL13078055 0.78 FFAR4 (0.42) POLBPARP10SLC6A2SLC6A4SLC6A3
SCHEMBL10174918 0.78 PARP10 (0.40) POLBPARP10SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4570313-A2 CYANOTRIAZOLE COMPOUNDS Otsuka Pharmaceutical Co., Ltd. (JP) 2025-06-18 EP disclosed
EP-4219477-A1 CYANOTRIAZOLE COMPOUNDS Otsuka Pharmaceutical Co., Ltd. (JP) 2023-08-02 EP disclosed
US-10626095-B2 Cyanotriazole compounds OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2020-04-21 US disclosed
US-20160229816-A1 CYANOTRIAZOLE COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2016-08-11 US disclosed
EP-3022199-A1 CYANOTRIAZOLE COMPOUNDS Otsuka Pharmaceutical Co., Ltd. (JP) 2016-05-25 EP disclosed
WO-2015008872-A1 CYANOTRIAZOLE COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2015-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10626095-B2 Cyanotriazole compounds CS, PC, ACAT1 POLB 539/4885PARP10 3605/4885ALDH1A1 1611/4885
US-20160229816-A1 CYANOTRIAZOLE COMPOUNDS CS, PC, ACAT1 POLB 539/4885PARP10 3605/4885ALDH1A1 1611/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.